Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles

Neurochemistry International

Volumn 61, Issue 7, 2012, Pages 1065-1071

  Chaturvedi, Mayank ^a,b   Figiel, Izabela ^a   Sreedhar, Bojja ^b   Kaczmarek, Leszek ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Excitotoxicity; Hippocampal slice cultures; MMP 9; Neuroprotection; PLGA nanoparticles; TIMP 1

Indexed keywords

GELATINASE; GELATINASE B; KAINIC ACID; LACTATE DEHYDROGENASE; NANOPARTICLE; POLYLACTIC ACID; PROPIDIUM IODIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ASSAY; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL EXCITABILITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE;

ANIMALS; HEK293 CELLS; HUMANS; NANOPARTICLES; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84870057734     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.07.023     Document Type: Article

References (23)

1. A.H. Baker, V. Sica, L.M. Work, S. Williams-Ignarro, F. De Nigris, L.O. Lerman, A. Casamassimi, A. Lanza, C. Schiano, and M. Rienzo Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia Proc. Natl. Acad. Sci. USA 104 2007 3597 3602 Pubmed: 17360688
2. R. Chirco, X.W. Liu, K.K. Jung, and H.R.C. Kim Novel functions of TIMPs in cell signaling Cancer Metastasis Rev. 25 2006 99 113 Pubmed: 16680576
3. A.W. Clark, C.A. Krekoski, S.S. Bou, K.R. Chapman, and D.R. Edwards Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia Neurosci. Lett. 238 1997 53 56 Pubmed: 9464653
4. M. Fujimoto, Y. Takagi, T. Aoki, M. Hayase, T. Marumo, M. Gomi, M. Nishimura, H. Kataoka, N. Hashimoto, and K. Nozaki Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia J. Cereb. Blood Flow Metab. 28 2008 1674 1685 Pubmed: 18560439
5. D. Gomez, D. Alonso, H. Yoshiji, and U. Thorgeirsson Tissue inhibitors of metalloproteinases: structure, regulation and biological functions Eur. J. Cell Biol. 74 1997 111 Pubmed: 9352216
6. J. Jourquin, E. Tremblay, N. Decanis, G. Charton, S. Hanessian, A.M. Chollet, T. Le Diguardher, M. Khrestchatisky, and S. Rivera Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate Eur. J. Neurosci. 18 2003 1507 1517 Pubmed: 14511330
7. Kaczmarek, L.; in press. MMP-9 inhibitors in the brain: can old bullets shoot new targets? Curr. Pharm. Des.
8. Y. Kawasaki, Z.Z. Xu, X. Wang, J.Y. Park, Z.Y. Zhuang, P.H. Tan, Y.J. Gao, K. Roy, G. Corfas, and E.H. Lo Distinct roles of matrix metalloproteases in the early-and late-phase development of neuropathic pain Nat. Med. 14 2008 331 336 Pubmed: 18264108
9. M. Koistinaho, T.M. Malm, M.I. Kettunen, G. Goldsteins, S. Starckx, R.A. Kauppinen, G. Opdenakker, and J. Koistinaho Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9- deficient mice J. Cereb. Blood Flow Metab. 25 2005 460 467 Pubmed: 22186671
10. S. Lorenzl, D.S. Albers, N. Relkin, T. Ngyuen, S.L. Hilgenberg, J. Chirichigno, M.E. Cudkowicz, and M.F. Beal Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease Neurochem. Int. 43 2003 191 196 Pubmed: 12689599
11. P. Michaluk, M. Wawrzyniak, P. Alot, M. Szczot, P. Wyrembek, K. Mercik, N. Medvedev, E. Wilczek, M. De Roo, and W. Zuschratter Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology J. Cell Sci. 124 2011 3369 3380 Pubmed: 21896646
12. B. Mioduszewska, J. Jaworski, A.W. Szklarczyk, A. Klejman, and L. Kaczmarek Inducible cAMP early repressor (ICER)-evoked delayed neuronal death in the organotypic hippocampal culture J. Neurosci. Res. 86 2008 61 70 Pubmed: 17722060
13. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347 Pubmed: 12628320
14. S. Rivera, M. Khrestchatisky, L. Kaczmarek, G.A. Rosenberg, and D.M. Jaworski Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J. Neurosci. 30 2010 15337 15357 Pubmed: 21084591
15. H. Rooprai, and D. Mccormick Proteases and their inhibitors in human brain tumours: a review Anticancer Res. 17 1997 4151 4162 Pubmed: 9428349
16. A. Rosell, A. Ortega-Aznar, J. Alvarez-Sabín, I. Fernández-Cadenas, M. Ribó, C.A. Molina, E.H. Lo, and J. Montaner Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke Stroke 37 2006 1399 4066 Pubmed: 16690896
17. Q.X. Sang, M. Muroski, M. Roycik, R. Newcomer, P. Van Den Steen, G. Opdenakker, H. Monroe, and Z. Sahab Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis Curr. Pharm. Biotechnol. 9 2008 34 46 Pubmed: 18289055
18. T. Sharshar, M.C. Durand, J.P. Lefaucheur, F. Lofaso, J.C. Raphaël, R. Gherardi, and A. Creange MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barré syndrome Neurology 59 2002 1649 1651 Pubmed: 12451218
19. W.G. Stetler-Stevenson Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities Sci. Signal. 1 2008 re6 Pubmed: 18612141
20. P. Svedin, H. Hagberg, K. Savman, C. Zhu, and C. Mallard Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia J. Neurosci. 27 2007 1511 1518 Pubmed: 17301159
21. E. Tejima, S. Guo, Y. Murata, K. Arai, J. Lok, K. Van Leyen, A. Rosell, X. Wang, and E.H. Lo Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1 J. Neurotrauma 26 2009 1935 1941 Pubmed: 2822804
22. P. Yin, L. Yang, H.Y. Zhou, and R.P. Sun Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy Med. Hypotheses 76 2011 184 186 Pubmed: 20888701
23. H. Zhang, M. Chang, C.N. Hansen, D.M. Basso, and L.J. Noble-Haeusslein Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury Neurotherapeutics 2011 1 15 Pubmed: 21455784